Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.
Industry, Sector and Symbol
Industry Laboratory apparatus & furniture
Sub-IndustryN/A
SectorComputer and Technology
Phone631-694-9555
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$36.68 million
Profitability
Miscellaneous
Employees118
OptionableNot Optionable
Misonix (NASDAQ:MSON) Frequently Asked Questions
What is Misonix's stock symbol?
Misonix trades on the NASDAQ under the ticker symbol "MSON."
How were Misonix's earnings last quarter?
Misonix, Inc. (NASDAQ:MSON) released its earnings results on Wednesday, February, 6th. The medical equipment provider reported ($0.09) EPS for the quarter, topping analysts' consensus estimates of ($0.15) by $0.06. The medical equipment provider earned $10.18 million during the quarter. Misonix had a negative net margin of 7.37% and a negative return on equity of 12.94%. View Misonix's Earnings History.
When is Misonix's next earnings date?
What price target have analysts set for MSON?
2 equities research analysts have issued 1 year price targets for Misonix's stock. Their predictions range from $24.00 to $28.00. On average, they expect Misonix's stock price to reach $26.00 in the next twelve months. This suggests a possible upside of 40.3% from the stock's current price. View Analyst Price Targets for Misonix.
What is the consensus analysts' recommendation for Misonix?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Misonix in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Misonix.
Has Misonix been receiving favorable news coverage?
News stories about MSON stock have trended neutral this week, according to InfoTrie. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Misonix earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned media headlines about the medical equipment provider a news buzz of 9.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near future.
Who are some of Misonix's key competitors?
Some companies that are related to Misonix include Unisys (UIS), ADTRAN (ADTN), ORBCOMM (ORBC), Nova Measuring Instruments (NVMI), Himax Technologies (HIMX), QuinStreet (QNST), Sapiens International (SPNS), eXp World (EXPI), i3 Verticals (IIIV), Smart Global (SGH), Vista Group International (VGL), Quantenna Communications (QTNA), Comtech Telecomm. (CMTL), Onespan (OSPN) and IQE (IQEPF).
Who are Misonix's key executives?
Misonix's management team includes the folowing people:
- Mr. Stavros George Vizirgianakis, Pres, CEO & Director (Age 49)
- Mr. Joseph P. Dwyer, CFO, Treasurer & Sec. (Age 63)
- Mr. Robert Scott Ludecker, Sr. VP of Global Sales & Marketing (Age 52)
- Mr. Dan Voic, VP of R&D & Engineering (Age 57)
- Mr. Christopher H. Wright, VP of Domestic Sales (Age 44)
Who are Misonix's major shareholders?
Misonix's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (3.83%), Geode Capital Management LLC (0.37%), Wesbanco Bank Inc. (0.29%), Acadian Asset Management LLC (0.10%) and ClariVest Asset Management LLC (0.10%). Company insiders that own Misonix stock include Christopher H Wright, Joseph J Brennan, Joseph P Dwyer, Patrick A Mcbrayer and Thomas M Patton. View Institutional Ownership Trends for Misonix.
Which major investors are selling Misonix stock?
MSON stock was sold by a variety of institutional investors in the last quarter, including ClariVest Asset Management LLC and Dimensional Fund Advisors LP. Company insiders that have sold Misonix company stock in the last year include Christopher H Wright and Joseph J Brennan. View Insider Buying and Selling for Misonix.
Which major investors are buying Misonix stock?
MSON stock was purchased by a variety of institutional investors in the last quarter, including Wesbanco Bank Inc., Geode Capital Management LLC and Acadian Asset Management LLC. Company insiders that have bought Misonix stock in the last two years include Joseph P Dwyer, Patrick A Mcbrayer and Thomas M Patton. View Insider Buying and Selling for Misonix.
How do I buy shares of Misonix?
Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Misonix's stock price today?
One share of MSON stock can currently be purchased for approximately $18.53.
How big of a company is Misonix?
Misonix has a market capitalization of $177.65 million and generates $36.68 million in revenue each year. Misonix employs 118 workers across the globe.
What is Misonix's official website?
How can I contact Misonix?
Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555.
MarketBeat Community Rating for Misonix (NASDAQ MSON)
MarketBeat's community ratings are surveys of what our community members think about Misonix and other stocks. Vote "Outperform" if you believe MSON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MSON will underperform the S&P 500 over the long term. You may vote once every thirty days.
